92 results
Page 3 of 5
424B5
vz1fwtts tm
11 Aug 21
Prospectus supplement for primary offering
6:56am
8-K
EX-4.1
a4r3o d2920
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
EX-4.2
5a2gnyv
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
424B3
5yi2j8c
30 Apr 21
Prospectus supplement
5:01pm
8-K
EX-4.1
a7jlcb2xlip2wccm
6 Jan 21
EyeGate Enters Into Agreement for $8.0 Million Private Placement
6:55am
8-K
EX-3.1
8bduyop527k409rs
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
8-K
bun8yrek
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
424B5
0vnxlaolp8 5bmhlwl
31 Dec 19
Prospectus supplement for primary offering
4:28pm
8-K
EX-4.1
z68 wmsz40e5sm
31 Dec 19
EyeGate Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm